Background: Recent evidence suggests that speech substantially changes in ageing. As a complex neurophysiological process, it can accurately reflect changes in the motor and cognitive systems underpinning human speech. Since healthy ageing is not always easily discriminable from early stages of dementia based on cognitive and behavioural…

The number of people diagnosed with Alzheimer's disease (AD), a progressive and terminal kind of dementia, continues to rise with an estimated 14 million Americans affected by 2050. Prior to an AD diagnosis, many individuals are diagnosed with mild cognitive impairment (MCI) and have similar, but less severe, symptoms as those with AD. A common…

Primary care physicians play a central role in the process of providing a timely diagnosis of Alzheimer's disease (AD). Recent reviews reported that their lack of knowledge and stigmatic beliefs about the disease are important barriers to providing an adequate diagnosis and even affect physicians' referral recommendations for help-seeking (HS).…

Advances in dual-retrieval models of recall make it possible to use clinical data to test theoretical hypotheses about mild cognitive impairment (MCI) and Alzheimer's dementia (AD), the most common forms of neurocognitive impairment. Hypotheses about the nature of the episodic memory declines in these diseases, about decline versus sparing of…

A randomized controlled trial examined whether the diagnostic process for Alzheimer's disease and other dementias may be influenced by knowledge of the patient's education and/or self-reported race. Four conditions were implemented: diagnostic team knows (a) race and education, (b) education only, (c) race only, or (d) neither. Diagnosis and…

Alzheimer's dementia (AD) is a progressive, degenerative disease that occurs in the cerebral cortex due to increased levels of glutamate, the proliferation of plaque-forming amyloid beta proteins, and reactive gliosis. Establishing behavioral indicators of the disease (e.g., impairments of episodic memory) and use of neuroimaging technology…

Background: Research addressing the experiences of families of adults with Down syndrome and Alzheimer's disease in seeking diagnosis and gaining support is limited. The aim of this study was to gain a greater understanding of these processes by exploring the experiences of families and carers in supporting people with Down syndrome and…

Changes in psychiatric symptoms related to specific stages of dementia were investigated in 224 adults 45 years of age or older with Down syndrome. Findings indicate that psychiatric symptoms are a prevalent feature of dementia in the population with Down syndrome and that clinical presentation is qualitatively similar to that seen in Alzheimer's…

Purpose: This study provides preliminary evidence for the acceptability, reliability, and validity of the new Alzheimer's Disease Knowledge Scale (ADKS), a content and psychometric update to the Alzheimer's Disease Knowledge Test. Design and Methods: Traditional scale development methods were used to generate items and evaluate their psychometric…

Examined demographic characteristics of 242 clinic outpatients evaluated for dementia. Each individual received comprehensive assessment of medical status, psychological functioning, and social abilities. Results add to knowledge of characteristics of individuals with Alzheimer's disease, multi-infarct dementia, or other related disorders.…

Explores the reasons that dementia is poorly understood and managed and suggests ways in which obstacles to optimal management of dementia can be overcome through research and through development of evidence-based services. (Author/JOW)

Background: The clinical and neuropathological features associated with dementia in Down's syndrome (DS) are not well established. Aims: To examine clinico-pathological correlations and the incidence of cognitive decline in a cohort of adults with DS. Method: A total of 92 hospitalized persons with DS were followed up from 1985 to December 2000.…

Institutionalized patients with Down syndrome (N=307) were monitored for 5 to 10 years to determine prevalence of Alzheimer-type dementia. Prevalence increased from 11% between ages 40 and 49 to 77% between 60 and 69. All patients 70 and over had dementia. Mean age of onset of dementia was 56 years. Neuropathological findings were consistent with…

Notes that, as American population ages and mental health counselors focus services on older adults, the identification, diagnosis, assessment, and treatment of dementia will become valuable clinical skill. Presents nontechnical information regarding dementia, including Alzheimer's disease, multi-infarct dementia, testing, and therapeutic…

This report describes the status of 70 adults (ages 22 to 60 at the longitudinal study's beginning) with Down syndrome who are being followed for signs of dementia. After 10 years, 12 met all criteria for dementia, 40 met subsets of criteria, and 18 met no criteria. Information is provided on choice and revision of instruments and dementia…